CY1117573T1 - BARONIC AS ARGINATION Suspensions - Google Patents
BARONIC AS ARGINATION SuspensionsInfo
- Publication number
- CY1117573T1 CY1117573T1 CY20161100317T CY161100317T CY1117573T1 CY 1117573 T1 CY1117573 T1 CY 1117573T1 CY 20161100317 T CY20161100317 T CY 20161100317T CY 161100317 T CY161100317 T CY 161100317T CY 1117573 T1 CY1117573 T1 CY 1117573T1
- Authority
- CY
- Cyprus
- Prior art keywords
- argination
- baronic
- suspensions
- arginase
- activity
- Prior art date
Links
Landscapes
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Abstract
Οι χημικές ενώσεις σύμφωνα με τον Χημικό Τύπο I είναι δυνατοί αναστολείς της δραστηριότητας της αργινάσης I και II, όπου τα R1, R2, R3, R4, D, W, Χ, Υ και Ζ ορίζονται στις προδιαγραφές. Η εφεύρεση παρέχει ακόμη φαρμακευτικές συνθέσεις των χημικών ενώσεων και μεθόδους για τη χρήση τους κατά την αντιμετώπιση ή πρόληψη ασθενειών ή παθήσεων σχετικών με τη δραστηριότητα της αργινάσης.The compounds according to Formula I are potent inhibitors of arginase I and II activity, wherein R1, R2, R3, R4, D, W, X, Y and Z are specified in the specification. The invention further provides pharmaceutical compositions of the compounds and methods for their use in the treatment or prevention of diseases or conditions related to arginase activity.
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US40676010A | 2010-10-26 | 2010-10-26 | |
| EP11779904.9A EP2632927B1 (en) | 2010-10-26 | 2011-10-19 | Boronates as arginase inhibitors |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| CY1117573T1 true CY1117573T1 (en) | 2017-04-26 |
Family
ID=58606649
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CY20161100317T CY1117573T1 (en) | 2010-10-26 | 2016-04-18 | BARONIC AS ARGINATION Suspensions |
Country Status (1)
| Country | Link |
|---|---|
| CY (1) | CY1117573T1 (en) |
-
2016
- 2016-04-18 CY CY20161100317T patent/CY1117573T1/en unknown
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| CY1122707T1 (en) | HETEROCYCLIC GLUTAMINASE INHIBITORS | |
| CY1121694T1 (en) | BICYCLIC-FUSED HETEROARYL OR ARYL COMPOUNDS AND THEIR USE AS IRAK4 INHIBITORS | |
| CY1118909T1 (en) | Oxalic acid amides as neprilysine suspensions, their pharmaceutical composition and their preparation | |
| CY1123626T1 (en) | HETEROCYCLIC PROTEIN KINASE INHIBITORS | |
| CY1118129T1 (en) | 5-ALKYNYL-PYRIMIDINES | |
| CY1118143T1 (en) | Heterocyclic compounds useful as PDK1 inhibitors | |
| CY1119620T1 (en) | NEPRILYSIN Suspensions | |
| CY1118681T1 (en) | NEPRILYSIN Suspensions | |
| CY1122279T1 (en) | NAPHTHIRIDINE COMPOUNDS JAK KINASE INHIBITORS | |
| CY1120031T1 (en) | N-ACYLOSULFONAMIDIS SOLUTIONAL AUTOMOBILES | |
| CY1121854T1 (en) | ARYLOAZOL-2-YL CYANOETHYLAMINE COMPOUNDS, METHOD OF MANUFACTURE AND METHOD OF USE THEREOF | |
| CY1118860T1 (en) | NEW DISASPYROCYCLOGANIA AND AZASPYROCYCALCANIA | |
| CY1118340T1 (en) | MOVEMENT SUSPENSIONS | |
| CY1119134T1 (en) | NEPRILYSIN CONCEPTS | |
| CY1120318T1 (en) | Substituted benzylindazoles for use as BUB1 kinase inhibitors in the treatment of hyperplasia patients | |
| CY1117200T1 (en) | Benzylamine derivatives as suspensions | |
| CY1119714T1 (en) | SUSPENSION UNIONS | |
| CY1121804T1 (en) | NOVEL PYRIMIDINE AND PYRIDINE COMPOUNDS AND THEIR USE | |
| CY1116034T1 (en) | 2-ANILINOBENZIMIDAZOL-6-CARBOXAMIDES AS ANTI-INFLAMMATIVE FACTORS | |
| CY1119387T1 (en) | TRIAZOLOPYRAZINS AS BRD4 INHIBITORS FOR USE IN CANCER TREATMENT | |
| CY1117105T1 (en) | PYRIDAZINONIN COMPOUNDS AND USE AS DAAO SUSPENSIONS | |
| CY1118004T1 (en) | SUSPENSIONS CDK | |
| CY1120420T1 (en) | SULFONYLOPEPERININ PRODUCTS AND THEIR USE FOR THE PROTECTION OF PROCINETINE MEDIATION | |
| CY1117197T1 (en) | TRIAZOLOPYRIDINE COMPOUNDS AS RIM kinase inhibitors | |
| CY1121677T1 (en) | COMPOUNDS OF DIMETHYLOBENZOIC ACID |